pixCellServices

You Define the Study.We Provide the Tools.

From discovery to toxicology, pixCellServices delivers flexible study design powered by human-relevant iPSC models, advanced phenomics, and Al-driven analysis.

Start your project here

Trusted by leading biopharma partners for predictive biology and custom studies.

Disease modeling

CRISPR cell models

iPSC research services

Biological studies

Phenomics screening

YOUR RESEARCH, DESIGNED YOUR WAY

pixCellServices Empowers You to Design Complete, End-to-End Biological Studies With Unparalleled Flexibility

Define your study goals — from toxicology to MoA — then choose from our validated pixCell models, your own iPSCs, or custom-engineered variants. Configure assays to match your workflow, and receive curated data packages with raw images, analytics, and AI-powered insights.

Complete End-to-End Control

Maintain oversight from initial design to final data delivery. We execute your vision while you keep full ownership of the research process and outcomes.

Adaptable to Any Research Scale

Whether it's testing individual targets or screening large libraries, our platform easily scales to the scope and timeframe of your project.

More Than "Just Data"

Receive more than just datasets - get machine learning-powered analysis through our secure data SaaS platform or pair with optional cell delivery.

HOW IT WORKS

Your Study in Four Simple Steps

From initial concept to final insights - a streamlined process in as little as 3 weeks.

Define Your Study Goals

Target research, disease modeling, toxicology, or mechanism of action (MoA), your goal is the foundation of everything we build together.

Choose Your Cellular Model

Choose from our portfolio of proven pixCell models, use your own iPSCs or those engineered with CRISPR to address your specific question.

Configure Your Screen

Customised compound libraries from small molecules to biologics. Choose your assay strategy looking at functional (pixCellServices) and phenotypic (pixCellPaint) readouts.

Receive Your Data Package

From raw images and structured data to machine learning-based analytics—with the added bonus of physical cell delivery for further validation.

“pixlbio’s unique combination of large scale automated Cell Painting capability, the high quality of the generated data, as well as their expertise in AI and predictive modelling, made them an obvious choice for AstraZeneca.”

Bjarki Johannesson

Director of Safety Innovation, AstraZeneca

“pixlbio, was selected for the Sanofi iDEA-TECH Awards Program to receive Sanofi’s support for its project due to their demonstrated ability to develop high-quality predictive models from their exceptional data. Within the funded project, the pixlbio team showcased profound expertise in Cell painting for morphological profiling, automation, AI and predictive modelling, which truly validates them as deserving awardees.”

Bodo Brunner

Head of In Vitro Biology and Cell Sample Technologies, Sanofi

“pixlbio’s cellular models have significantly improved our Go-No/Go translational decisions across multiple programs over the years at Deep Genomics. The hepatic cell systems are far superior and physiologically relevant compared to commonly used cell lines. More recently, we have begun testing disease variant carrying models, further improving translatability of our screening systems. Working with both the BD and technical support teams at pixlbio has been an excellent experience. Response times have been very fast and technical support and information provided has been above and beyond on a regular basis. We are looking forward to working on additional systems coming from the pixlbio team.”

Denis Gallagher

Principal Scientist, Deep Genomics